ZYXI (Zynex Corp) חוב כולל להון

Zynex, Inc. (ZYXI) dominates the rehabilitation niche through its unique NexWave systems, offering an effective alternative to opioids. Company management ensures strict resource optimization and high direct sales growth rates. This price chart reflects the debt-to-equity ratio, which currently stands at 0.00. Service stability is maintained through streamlined equipment delivery chains and remote user support.

Zynex, Inc. occupies a stable niche in the medtech sector, leveraging an optimized equipment distribution system via internal warehouse hubs. An analysis of the D/E ratio (total debt to equity) allows for an assessment of the proportion of borrowed funds to equity assets, where a decrease in this metric indicates deleveraging and increased financial autonomy, fundamentally strengthening the business's resilience to market shocks.